Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 222,786,589 papers from all fields of science
Search
Sign In
Create Free Account
TK2 gene
Known as:
Thymidine Kinase 2, Mitochondrial Gene
, SCA31
, THYMIDINE KINASE, MITOCHONDRIAL
Expand
This gene plays a role in mitochondrial DNA synthesis in non-replicating cells.
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
3 relations
DNA Replication
Phosphorylation
TK2 protein, human
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
Distinctive features of degenerating Purkinje cells in spinocerebellar ataxia type 31
Kunihiro Yoshida
,
Mika Asakawa
,
+4 authors
K. Oyanagi
Neuropathology (Kyoto. )
2013
Corpus ID: 8789397
Spinocerebellar ataxia type 31 (SCA31) is an autosomal dominant form of pure cerebellar ataxia that is caused by a disease…
Expand
2012
2012
Adult cases of mitochondrial DNA depletion due to TK2 defect
A. Béhin
,
C. Jardel
,
+6 authors
A. Lombès
Neurology
2012
Corpus ID: 25656463
Objective: In this study we aim to demonstrate the occurrence of adult forms of TK2 mutations causing progressive mitochondrial…
Expand
2011
2011
Two dominantly inherited ataxias linked to chromosome 16q22.1: SCA4 and SCA31 are not allelic
Ulf Edener
,
V. Bernard
,
Y. Hellenbroich
,
G. Gillessen‐Kaesbach
,
C. Zühlke
Journal of Neurology
2011
Corpus ID: 22644988
Autosomal dominant spinocerebellar ataxias (SCAs) are heterogeneous neurological disorders characterised by cerebellar…
Expand
2011
2011
Comparisons of acoustic function in SCA31 and other forms of ataxias
Y. Ikeda
,
M. Nagai
,
+8 authors
K. Abe
Neurological Research
2011
Corpus ID: 23497457
Abstract Objective: To investigate whether acoustic impairment can be one of the characteristic extracerebellar symptoms in…
Expand
2010
2010
Analysis of an insertion mutation in a cohort of 94 patients with spinocerebellar ataxia type 31 from Nagano, Japan
Haruya Sakai
,
Kunihiro Yoshida
,
Y. Shimizu
,
H. Morita
,
S. Ikeda
,
N. Matsumoto
Neurogenetics
2010
Corpus ID: 16147105
Spinocerebellar ataxia type 31 (SCA31) is a recently defined subtype of autosomal dominant cerebellar ataxia (ADCA) characterized…
Expand
2000
2000
Expression of human mitochondrial thymidine kinase in Escherichia coli: correlation between the enzymatic activity of pyrimidine nucleoside analogues and their inhibitory effect on bacterial growth.
J. Wang
,
C. Su
,
J. Neuhard
,
S. Eriksson
Biochemical Pharmacology
2000
Corpus ID: 29347569
1999
1999
Stereoisomeric selectivity of human deoxyribonucleoside kinases.
Jianghai Wang
,
D. Choudhury
,
J. Chattopadhyaya
,
S. Eriksson
Biochemistry
1999
Corpus ID: 7711024
Deoxynucleoside kinases catalyze the 5'-phosphorylation of 2'-deoxyribonucleosides with nucleoside triphosphates as phosphate…
Expand
1999
1999
Substrate/inhibitor properties of human deoxycytidine kinase (dCK) and thymidine kinases (TK1 and TK2) towards the sugar moiety of nucleosides, including O'-alkyl analogues.
B. Kierdaszuk
,
K. Krawiec
,
+5 authors
D. Shugar
Nucleosides and Nucleotides
1999
Corpus ID: 36914875
Nucleoside analogues with modified sugar moieties have been examined for their substrate/inhibitor specificities towards highly…
Expand
Highly Cited
1992
Highly Cited
1992
Thymidine and 3'-azido-3'-deoxythymidine metabolism in human peripheral blood lymphocytes and monocyte-derived macrophages. A study of both anabolic and catabolic pathways.
Elias S. J. Arnér
,
A. Valentin
,
S. Eriksson
Journal of Biological Chemistry
1992
Corpus ID: 20447611
1991
1991
Deoxynucleoside phosphorylating enzymes in monkey and human tissues show great similarities, while mouse deoxycytidine kinase has a different substrate specificity.
A. Habteyesus
,
A. Nordenskjöld
,
C. Bohman
,
S. Eriksson
Biochemical Pharmacology
1991
Corpus ID: 9714325
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE